Emerald Bioscience, Inc. Human Resources Contracts & Agreements
19 Contracts & Agreements
- Bonus & Incentive Agreements (10 contracts)
- Change of Control Agreements (1)
- Employment Agreements (5)
- Separation Agreements (3)
- 2024 Inducement Equity Incentive Plan (Filed With SEC on August 9, 2024)
- Amendment No 1 to Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on October 3, 2023)
- Amendment to Executive Employment Agreement (Filed With SEC on May 12, 2023)
- Form of Stock Option Award - For Canadian Optionees under Amended and Restated 2014 Omnibus Incentive Plan (Filed With SEC on November 14, 2022)
- Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (ISO) (Filed With SEC on August 15, 2022)
- Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on August 15, 2022)
- Form of Restricted Stock Unit Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on March 28, 2022)
- Executive Employment Agreement, dated October 4, 2021, by and between the Company and Kaitlyn Arsenault (Filed With SEC on October 6, 2021)
- Amendment No. 2 to 2014 Omnibus Incentive Plan (Filed With SEC on August 12, 2020)
- Employment Agreement, dated August 10, 2020, by and between Emerald Bioscience, Inc. and Punit Dhillon (Filed With SEC on August 12, 2020)
- Separation and Release Agreement, dated August 7, 2020, by and between Emerald Bioscience, Inc. and Brian Murphy (Filed With SEC on August 12, 2020)
- Separation and Release Agreement, dated April 29, 2020, between Emerald Bioscience, Inc. and Doug Cesario (Filed With SEC on April 29, 2020)
- Employment Agreement, dated as of August 16, 2019, by and between the Company and Dr. Dennis D. Kim (Filed With SEC on October 23, 2019)
- Amendment No. 1 to 2014 Omnibus Incentive Plan (Filed With SEC on October 12, 2018)
- Employment Agreement, dated May 25, 2018, between Nemus Bioscience, Inc. and Douglas Cesario (Filed With SEC on June 1, 2018)
- Separation and Release Agreement, dated April 30, 2018, between Nemus Bioscience, Inc. and Elizabeth Berecz (Filed With SEC on May 4, 2018)
- Nemus Bioscience, Inc. Officer Change in Control Severance Plan (Filed With SEC on February 27, 2015)
- Form of Stock Option Agreement under 2014 Omnibus Incentive Plan (Filed With SEC on November 3, 2014)
- Nemus Bioscience Inc. 2014 Omnibus Incentive Plan (Filed With SEC on November 3, 2014)
